Stomach sleeve device for obesity and metabolic syndrome
Part of Hormones & metabolism clinical trials.
This trial tests a tube-like device placed in the upper gut to help people with obesity and related health problems lose weight. It may be an option if you haven't lost a lot of weight recently or taken certain medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is 27.5 or higher, or 25 or higher with metabolic syndrome (like high blood sugar or cholesterol)
- You have not lost more than 11 pounds (5 kg) in the last 3 months
- You have not used certain diabetes or weight-loss drugs (like GLP-1 medications or orlistat) in the past 3 months
- You have not taken blood thinners (like aspirin) in the past month
- You have no serious bleeding, liver, kidney, or stomach problems
- You are not pregnant or planning pregnancy, and you have no allergies to the device materials
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
This study tests a new type of weight-loss surgery that combines a sleeve gastrectomy with a rerouting of part of the intestine. It is designed to help people with severe obesity lose weight and improve conditions like type 2 diabetes, and it may be an option for people who have already had a sleeve gastrectomy but need another procedure.
This study looks at factors that predict weight loss success after a non-surgical stomach reduction procedure (endoscopic sleeve gastroplasty). It may help if you have obesity-related health problems and have not succeeded with diet or lifestyle changes.
This trial studies a specific type of metabolic (weight-related) surgery for people whose sleeve gastrectomy did not lead to enough weight loss or has caused significant weight regain. It may help improve long-term weight and related health problems.
This trial tests a device placed in the intestine to help control blood sugar and support weight loss in people with type 2 diabetes and obesity. It may offer a new option for managing both conditions together.
This study tests if a procedure called endoscopic sleeve gastroplasty helps people with obesity and a liver condition called MASH lose weight and improve their liver health. It might be an option if you have both obesity and MASH and haven't had weight-loss surgery before.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.